Home › Compound Library › Growth Hormone Axis › Tesamorelin
Growth Hormone Axis Research High Evidence

Tesamorelin

Stabilized GHRH analogue (trans-3-hexenoic acid modification). FDA-approved for HIV-associated lipodystrophy. Extensively studied in multiple human RCTs.

ghrhFDAlipodystrophyvisceral fatcognitivegrowth hormone
Half-life
~26 minutes
SKUs Available
4
Evidence Level
High Evidence
Mechanism of Action

Modified GHRH with enhanced stability. Stimulates pulsatile GH secretion from pituitary; associated with preferential visceral adipose tissue reduction in trials.

Published Research Ranges & Study Context

Studies have administered: 1–2mg/day subcutaneous in clinical trials

Important Research Framing These are ranges reported in published scientific studies. They are provided for educational context only and do not constitute dosing recommendations. Individual study parameters vary by design, population, and research objectives. This information is not medical advice.
Primary Research Findings

Multiple RCTs (LASSO studies) demonstrate visceral adipose tissue reduction of 15–18%. Cognitive function improvements reported in mild cognitive impairment studies (NIMH-funded).

High Evidence Multiple large human RCTs available
Side Effects Observed in Research

Fluid retention, joint pain, injection site reactions; glucose monitoring recommended in diabetic subjects in trials

Available Configurations (SKU Reference)
TSM5 TSM10 TSM15 TSM20
Compounds Studied in Combination

These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.

Want a Complete Research Monograph?

Our AI can generate a 2,000+ word deep-dive on Tesamorelin — including full clinical trial summaries, pharmacokinetics, and research frontiers.

Generate Deep Dive in Research Chat
Research Education Only: This compound profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions. Regulatory status varies by jurisdiction.